The novel highly transmissible human coronavirus SARS-CoV-2 is the causative agent of the
COVID-19 pandemic. Thus far, there is no approved therapeutic drug specifically targeting …

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), exhibits high levels of mortality and morbidity and …

Public health experts emphasize the need for quick, point-of-care SARS-CoV-2 detection as
an effective strategy for controlling virus spread. To this end, many “antigen” detection …

In Narcissus tazetta, a monocotyledonous bulbous geophyte, floral initiation and differentiation
occur within the bulb during the quiescent period in summer, when ambient temperatures …

Neutralizing antibodies represent a valuable therapeutic approach to countermeasure the
current COVID-19 pandemic. Emergence of SARS-CoV-2 variants emphasizes the notion that …

Monoclonal antibodies represent an important avenue for COVID-19 therapy and are routinely
used for rapid and accessible diagnosis of SARS-CoV-2 infection. The recent emergence …

Ricin, derived from the castor bean plant Ricinus communis, is one of the most potent and
lethal toxins known, against which there is no available antidote. To date, the use of …

The eradication of smallpox was officially declared by the WHO in 1980, leading to
discontinuation of the vaccination campaign against the virus. Consequently, immunity against …

Members of the Orthopoxvirus genus can cause severe infections in humans. Global vaccination
against smallpox, caused by the variola virus, resulted in the eradication of the disease …

The use of passively-administered neutralizing antibodies is a promising approach for the
prevention and treatment of SARS-CoV-2 infection. Antibody-mediated protection may involve …